<DOC>
	<DOC>NCT01060475</DOC>
	<brief_summary>LIM-0705 dosed separately and in combination with tacrolimus will be safe and well tolerated.</brief_summary>
	<brief_title>Safety and Tolerability of LIM-0705 in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male age 1850 Patient in good health as deemed by prestudy exam and history BMI 2030 kg/sq. meter Absence of tremors Must be willing to remain in confinement for 17 days/16 nights Systolic BP 90140 mmHg, diastolic BP 5090 mmHg, resting HR 4590 bpm Subject must be nonsmoker or willing to abstain from smoking day 4 through day 30. Subject must abstain from alcohol, grapefruit,and caffeinecontaining beverages starting Day 2 through Day 30. Subjects must use doublebarrier contraception through course of study + 90 days following study Allergy to red wine or onions Strict vegetarians Use of any nonstudy medication Use of chemotherapy within 5 years prior to Screening visit Use of any dietary aids Difficultly swallowing oral medications cognitive or psychiatric disorders</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Transplant</keyword>
</DOC>